![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
PubMed:9765424
Annnotations
jnlpba-st-training
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-12 | DNA | denotes | CD4 promoter |
T2 | 113-121 | DNA | denotes | CD4 gene |
T3 | 154-166 | cell_line | denotes | CD4(-) cells |
T4 | 634-658 | DNA | denotes | reporter gene constructs |
T5 | 673-685 | DNA | denotes | CD4 promoter |
T6 | 743-759 | DNA | denotes | genetic elements |
T7 | 779-791 | DNA | denotes | CD4 promoter |
T8 | 906-954 | DNA | denotes | immediate-early and early classes of viral genes |
T9 | 992-1012 | DNA | denotes | CD4 promoter mutants |
T10 | 1031-1051 | DNA | denotes | ATF/CRE binding site |
T11 | 1063-1094 | DNA | denotes | nucleotides -67 to -60 upstream |
T12 | 1102-1135 | DNA | denotes | CD4 gene transcription start site |
T13 | 1185-1197 | DNA | denotes | ATF/CRE site |
T14 | 1220-1232 | DNA | denotes | CD4 promoter |
T15 | 1377-1383 | protein | denotes | CREB-1 |
T16 | 1410-1427 | DNA | denotes | -79 to -52 region |
T17 | 1435-1447 | DNA | denotes | CD4 promoter |
T18 | 1478-1497 | DNA | denotes | open reading frames |
T19 | 1499-1503 | DNA | denotes | ORFs |
T20 | 1515-1518 | DNA | denotes | U86 |
T21 | 1523-1526 | DNA | denotes | U89 |
T22 | 1588-1600 | DNA | denotes | CD4 promoter |
T23 | 1604-1614 | cell_line | denotes | HeLa cells |
T24 | 1648-1660 | DNA | denotes | CD4 promoter |
T25 | 1664-1668 | DNA | denotes | ORFs |
T26 | 1669-1672 | DNA | denotes | U86 |
T27 | 1677-1680 | DNA | denotes | U89 |
T28 | 1703-1714 | DNA | denotes | CRE element |
T29 | 1743-1753 | DNA | denotes | HHV-6 ORFs |
T30 | 1782-1790 | DNA | denotes | CD4 gene |
T31 | 1912-1924 | DNA | denotes | CD4 promoter |
T32 | 1983-2004 | protein | denotes | transcription factors |
T33 | 2032-2040 | DNA | denotes | CD4 gene |
pubmed-sentences-benchmark
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
S1 | 0-52 | Sentence | denotes | CD4 promoter transactivation by human herpesvirus 6. |
S2 | 53-555 | Sentence | denotes | The observation that human herpesvirus 6 (HHV-6) can induce CD4 gene transcription and expression in CD4(-) cells was reported several years ago (P. Lusso, A. De Maria, M. Malnati, F. Lori, S. E. DeRocco, M. Baseler, and R. C. Gallo, Nature 349:533-535, 1991) and subsequently confirmed (P. Lusso, M. S. Malnati, A. Garzino-Demo, R. W. Crowley, E. O. Long, and R. C. Gallo, Nature 362:458-462, 1993; G. Furlini, M. Vignoli, E. Ramazzotti, M. C. Re, G. Visani, and M. LaPlaca, Blood 87:4737-4745, 1996). |
S3 | 556-627 | Sentence | denotes | Our objective was to identify the mechanisms underlying such phenomena. |
S4 | 628-760 | Sentence | denotes | Using reporter gene constructs driven by the CD4 promoter, we report that HHV-6 can efficiently transactivate such genetic elements. |
S5 | 761-955 | Sentence | denotes | Activation of the CD4 promoter occurs in the presence of the viral DNA polymerase inhibitor phosphonoformic acid, which limits expression to the immediate-early and early classes of viral genes. |
S6 | 956-1180 | Sentence | denotes | Using deletion mutants and specific CD4 promoter mutants, we identified an ATF/CRE binding site located at nucleotides -67 to -60 upstream of the CD4 gene transcription start site that is important for HHV-6 transactivation. |
S7 | 1181-1292 | Sentence | denotes | The ATF/CRE site is also essential for CD4 promoter activation by forskolin, an activator of adenylate cyclase. |
S8 | 1293-1448 | Sentence | denotes | Using electrophoretic mobility shift assays and specific antibodies, we showed that CREB-1 binds specifically to the -79 to -52 region of the CD4 promoter. |
S9 | 1449-1615 | Sentence | denotes | Last, we have identified two open reading frames (ORFs) of HHV-6, U86 and U89 from the immediate-early locus A, that can transactivate the CD4 promoter in HeLa cells. |
S10 | 1616-1802 | Sentence | denotes | However, transactivation of the CD4 promoter by ORFs U86 and U89 is independent of the CRE element, suggesting that additional HHV-6 ORFs are likely to contribute to CD4 gene activation. |
S11 | 1803-2052 | Sentence | denotes | Taken together, our results will help to understand the complex interactions occurring between HHV-6 and the CD4 promoter and provide additional information regarding the class of transcription factors involved in the control of CD4 gene expression. |
genia-medco-coref
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
C1 | 32-51 | NP | denotes | human herpesvirus 6 |
C2 | 74-101 | NP | denotes | human herpesvirus 6 (HHV-6) |
C3 | 669-685 | NP | denotes | the CD4 promoter |
C4 | 702-707 | NP | denotes | HHV-6 |
C5 | 775-791 | NP | denotes | the CD4 promoter |
C6 | 818-873 | NP | denotes | the viral DNA polymerase inhibitor phosphonoformic acid |
C7 | 875-880 | NP | denotes | which |
C9 | 1098-1135 | NP | denotes | the CD4 gene transcription start site |
C10 | 1136-1140 | NP | denotes | that |
C8 | 1028-1179 | NP | denotes | an ATF/CRE binding site located at nucleotides -67 to -60 upstream of the CD4 gene transcription start site that is important for HHV-6 transactivation |
C11 | 1181-1197 | NP | denotes | The ATF/CRE site |
C12 | 1247-1256 | NP | denotes | forskolin |
C13 | 1258-1291 | NP | denotes | an activator of adenylate cyclase |
C14 | 1431-1447 | NP | denotes | the CD4 promoter |
C16 | 1508-1513 | NP | denotes | HHV-6 |
C15 | 1474-1513 | NP | denotes | two open reading frames (ORFs) of HHV-6 |
C17 | 1515-1559 | NP | denotes | U86 and U89 from the immediate-early locus A |
C18 | 1561-1565 | NP | denotes | that |
C19 | 1584-1600 | NP | denotes | the CD4 promoter |
C20 | 1644-1660 | NP | denotes | the CD4 promoter |
C21 | 1664-1680 | NP | denotes | ORFs U86 and U89 |
C22 | 1898-1903 | NP | denotes | HHV-6 |
C23 | 1908-1924 | NP | denotes | the CD4 promoter |
R1 | C2 | C1 | coref-ident | human herpesvirus 6 (HHV-6),human herpesvirus 6 |
R2 | C4 | C2 | coref-ident | HHV-6,human herpesvirus 6 (HHV-6) |
R3 | C5 | C3 | coref-ident | the CD4 promoter,the CD4 promoter |
R4 | C7 | C6 | coref-relat | which,the viral DNA polymerase inhibitor phosphonoformic acid |
R5 | C10 | C9 | coref-relat | that,the CD4 gene transcription start site |
R6 | C11 | C8 | coref-ident | The ATF/CRE site,an ATF/CRE binding site located at nucleotides -67 to -60 upstream of the CD4 gene transcription start site that is important for HHV-6 transactivation |
R7 | C13 | C12 | coref-appos | an activator of adenylate cyclase,forskolin |
R8 | C14 | C5 | coref-ident | the CD4 promoter,the CD4 promoter |
R9 | C16 | C4 | coref-ident | HHV-6,HHV-6 |
R10 | C17 | C15 | coref-appos | U86 and U89 from the immediate-early locus A,two open reading frames (ORFs) of HHV-6 |
R11 | C18 | C15 | coref-relat | that,two open reading frames (ORFs) of HHV-6 |
R12 | C19 | C14 | coref-ident | the CD4 promoter,the CD4 promoter |
R13 | C20 | C19 | coref-ident | the CD4 promoter,the CD4 promoter |
R14 | C21 | C15 | coref-ident | ORFs U86 and U89,two open reading frames (ORFs) of HHV-6 |
R15 | C22 | C16 | coref-ident | HHV-6,HHV-6 |
R16 | C23 | C20 | coref-ident | the CD4 promoter,the CD4 promoter |
GENIAcorpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-12 | DNA_domain_or_region | denotes | CD4 promoter |
T2 | 32-51 | virus | denotes | human herpesvirus 6 |
T3 | 74-93 | virus | denotes | human herpesvirus 6 |
T4 | 95-100 | virus | denotes | HHV-6 |
T5 | 113-121 | DNA_domain_or_region | denotes | CD4 gene |
T6 | 154-166 | cell_line | denotes | CD4(-) cells |
T7 | 634-658 | DNA_family_or_group | denotes | reporter gene constructs |
T8 | 673-685 | DNA_domain_or_region | denotes | CD4 promoter |
T9 | 702-707 | virus | denotes | HHV-6 |
T10 | 743-759 | DNA_family_or_group | denotes | genetic elements |
T11 | 779-791 | DNA_domain_or_region | denotes | CD4 promoter |
T12 | 828-852 | other_organic_compound | denotes | DNA polymerase inhibitor |
T13 | 853-873 | other_organic_compound | denotes | phosphonoformic acid |
T14 | 992-1004 | DNA_domain_or_region | denotes | CD4 promoter |
T15 | 1031-1051 | DNA_domain_or_region | denotes | ATF/CRE binding site |
T16 | 1063-1094 | DNA_domain_or_region | denotes | nucleotides -67 to -60 upstream |
T17 | 1102-1110 | DNA_domain_or_region | denotes | CD4 gene |
T18 | 1158-1163 | virus | denotes | HHV-6 |
T19 | 1185-1197 | DNA_domain_or_region | denotes | ATF/CRE site |
T20 | 1220-1232 | DNA_domain_or_region | denotes | CD4 promoter |
T21 | 1274-1291 | other_name | denotes | adenylate cyclase |
T22 | 1299-1336 | other_name | denotes | electrophoretic mobility shift assays |
T23 | 1377-1383 | protein_molecule | denotes | CREB-1 |
T24 | 1410-1427 | DNA_domain_or_region | denotes | -79 to -52 region |
T25 | 1435-1447 | DNA_domain_or_region | denotes | CD4 promoter |
T26 | 1478-1497 | DNA_family_or_group | denotes | open reading frames |
T27 | 1499-1503 | DNA_family_or_group | denotes | ORFs |
T28 | 1508-1513 | virus | denotes | HHV-6 |
T29 | 1515-1518 | DNA_domain_or_region | denotes | U86 |
T30 | 1523-1526 | DNA_domain_or_region | denotes | U89 |
T31 | 1588-1600 | DNA_domain_or_region | denotes | CD4 promoter |
T32 | 1604-1614 | cell_line | denotes | HeLa cells |
T33 | 1648-1660 | DNA_domain_or_region | denotes | CD4 promoter |
T34 | 1664-1668 | DNA_family_or_group | denotes | ORFs |
T35 | 1669-1672 | DNA_domain_or_region | denotes | U86 |
T36 | 1677-1680 | DNA_domain_or_region | denotes | U89 |
T37 | 1703-1714 | DNA_domain_or_region | denotes | CRE element |
T38 | 1743-1748 | virus | denotes | HHV-6 |
T39 | 1782-1790 | DNA_domain_or_region | denotes | CD4 gene |
T40 | 1898-1903 | virus | denotes | HHV-6 |
T41 | 1912-1924 | DNA_domain_or_region | denotes | CD4 promoter |
T42 | 1983-2004 | protein_family_or_group | denotes | transcription factors |
T43 | 2032-2040 | DNA_domain_or_region | denotes | CD4 gene |